SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-061299
Filing Date
2012-11-13
Accepted
2012-11-13 11:23:11
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v326006_10q.htm 10-Q 255791
2 CERTIFICATION v326006_ex31-1.htm EX-31.1 7530
3 CERTIFICATION v326006_ex31-2.htm EX-31.2 7683
4 CERTIFICATION v326006_ex32-1.htm EX-32.1 3540
5 CERTIFICATION v326006_ex32-2.htm EX-32.2 3534
  Complete submission text file 0001144204-12-061299.txt   2353348

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtus-20120930.xml EX-101.INS 191663
7 XBRL TAXONOMY EXTENSION SCHEMA vtus-20120930.xsd EX-101.SCH 38122
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtus-20120930_cal.xml EX-101.CAL 19594
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtus-20120930_def.xml EX-101.DEF 162770
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtus-20120930_lab.xml EX-101.LAB 314661
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtus-20120930_pre.xml EX-101.PRE 189919
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 121196917
SIC: 2834 Pharmaceutical Preparations